Johnson Pharmacare reports zero revenue and a massive annual loss.
Auditors have issued a qualified opinion, warning that the company cannot meet its upcoming liabilities and may no longer be a going concern.
— 2 earlier stories on Johnson Pharmacare Ltd. →What's new
- The company reported zero operational revenue for FY26.
- Statutory auditors flagged a lack of audit trails in accounting software.
- Auditors issued a qualified opinion, questioning the firm's status as a going concern.
Why this matters
A company with ₹55.73 crore in losses and ₹111.23 crore in cash losses against a ₹30 crore market cap is effectively insolvent. The auditor's warning about the company's inability to meet liabilities is a terminal signal for equity holders.
What we're watching
- Any potential delisting or regulatory intervention by SEBI.
- Whether the company provides a response to the auditor's findings.
- The status of remaining assets given the lack of operational revenue.
The full read
Johnson Pharmacare ended FY26 with zero operational revenue and a financial position that auditors describe as terminal. The company posted an annual net loss of ₹55.73 crore and cash losses of ₹111.23 crore. These figures dwarf the company's ₹30 crore market capitalization. Statutory auditors VRSK & Associates issued a qualified opinion, stating the company is likely unable to meet its liabilities over the next 12 months. The audit also uncovered severe governance failures, including non-compliance with Indian Accounting Standards and the absence of a mandatory audit trail in the company's accounting software. The auditor's explicit challenge to the company's status as a going concern leaves little room for interpretation. The firm is currently burning cash it does not have, with no revenue to offset the losses.
Questions answered
- What is the company's current financial status?
- Johnson Pharmacare is in extreme distress with zero operational revenue for FY26. It reported a net loss of ₹55.73 crore and cash losses of ₹111.23 crore.
- Why did the auditors issue a qualified opinion?
- VRSK & Associates concluded the company cannot meet its liabilities due within the next year. They also cited non-compliance with Indian Accounting Standards and missing audit trails in the accounting software.
- How does the loss compare to the company's market value?
- The annual net loss of ₹55.73 crore is nearly double the company's total market capitalization of ₹30 crore.
- What specific internal control issues were identified?
- The auditors found significant deficiencies, most notably the absence of a required audit trail feature in the company's accounting software.
Story so far
All notes on JOHNPHARMA →- 27 May 2026 · 7:56 PM IST Johnson Pharmacare reports zero revenue and a massive annual loss.
- today Johnson Pharmacare auditor issues going concern warning
- today Johnson Pharmacare auditor warns of insolvency risk